Stoichiometry and compartmentation in G protein-coupled receptor signaling: Implications for therapeutic interventions involving G(s)

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 2, 2000, Pages 407-412

  Ostrom, Rennolds S ^a   Post, Steven R ^b   Insel, Paul A ^a  

^a San Diego   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; REGULATOR PROTEIN;

ASTHMA; CELL COMPARTMENTALIZATION; CELL MEMBRANE; CONCENTRATION RESPONSE; CONGESTIVE HEART FAILURE; CYSTIC FIBROSIS; GENE THERAPY; HUMAN; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; STOICHIOMETRY;

ADENYLATE CYCLASE; ANIMALS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 0033943654     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Alousi AA, Jasper JR, Insel PA and Motulsky HJ (1991) Stoichiometry of receptor-Gs-adenylate cyclase interactions. FASEB J 5:2300-2303.
2. Anderson R (1998) The caveolae membrane system. Annu Rev Biochem 67:199-225.
3. Büscher R, Herrmann V and Insel PA (1999) Human adrenoceptor polymorphisms: Evolving recognition of clinical importance. Trends Pharmacol Sci 20:94-99.
4. Carman CV, Lisanti MP and Benovic JL (1999) Regulation of G protein-coupled receptor kinases by caveolin. J Biol Chem 274:8858-8864.
5. Chidiac P (1998) Rethinking receptor-G protein-effector interactions. Biochem Pharmacol 55:549-556.
6. Colledge M and Froehner SC (1998) Signals mediating ion channel clustering at the neuromuscular junction. Curr Opin Neurobiol 8:357-363.
7. Colledge M and Scott JD (1999) AKAPs: From structure to function. Trends Cell Biol 9:216-221.
8. Couet J, Sargiacomo M and Lisanti MP (1997) Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem 272:30429-30438.
9. de Weerd WF and Leeb-Lundberg LM (1997) Bradykinin sequesters B2 bradykinin receptors and the receptor-coupled G-alpha subunits G-alphaq and G-alphai in caveolae in DDT1 MF-2 smooth muscle cells. J Biol Chem 272:17858-17866.
10. Dohlman HG and Thorner J (1997) RGS proteins and signaling by heterotrimeric G proteins. J Biol Chem 272:3871-3874.
11. Fanning AS and Anderson JM (1999) PDZ domains: Fundamental building blocks in the organization of protein complexes at the plasma membrane. J Clin Invest 103:767-772.
12. Ferguson SS, Downey WE 3rd, Colapietro AM, Barak LS, Ménard L and Caron MG (1996) Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science (Wash DC) 271:363-366.
13. Feron O, Smith TW, Michel T and Kelly RA (1997) Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes. J Biol Chem 272:17744-17748.
14. Foord SM and Marshall FH (1999) RAMPs: Accessory proteins for seven transmembrane domain receptors. Trends Pharmacol Sci 20:184-187.
15. Gao M, Ping P, Post S, Insel PA, Tang R and Hammond HK (1998) Increased expression of adenylyl cyclase type VI proportionately increases beta-adrenergic receptor-stimulated production of cAMP in neonatal rat cardiac myocytes. Proc Natl Acad Sci USA 95:1038-1043.
16. Gao MH, Lai NC, Roth DM, Zhou J, Zhu J, Anzai T, Dalton N and Hammond HK (1999) Adenylylcyclase increases responsiveness to catecholamine stimulation in transgenic mice. Circulation 99:1618-1622.
17. Gaudin C, Ishikawa Y, Wight DC, Mahdavi V, Nadal-Ginard B, Wagner TE, Vatner DE and Homey CJ (1995) Overexpression of Gs alpha protein in the hearts of transgenic mice. J Clin Invest 95:1676-1683.
18. Goodman OB Jr, Krupnick JG, Santini F, Gurevich VV, Penn RB, Gagnon AW, Keen JH and Benovic JL (1996) beta-Arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature (Lond) 383:447-450.
19. Hildebrandt JD (1997) Role of subunit diversity in signaling by heterotrimeric G proteins. Biochem Pharmacol 54:325-339.
20. Hooper NM (1999) Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid rafts and caveolae (Review). Mol Membr Biol 16:145-156.
21. Jia H, Hingorani AD, Sharma P, Hopper R, Dickerson C, Trutwein D, Lloyd DD and Brown MJ (1999) Association of the G(s)alpha gene with essential hypertension and response to beta-blockade. Hypertension 34:8-14.
22. Kim SK (1997) Polarized signaling: Basolateral receptor localization in epithelial cells by PDZ-containing proteins. Curr Opin Cell Biol 9:853-859.
23. Krupnick JG and Benovic JL (1998) The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 38:289-319.
24. Kuschel M, Zhou YY, Spurgeon HA, Bartel S, Karczewski P, Zhang SJ, Krause EG, Lakatta EG and Xiao RP (1999) beta2-Adrenergic cAMP signaling is uncoupled from phosphorylation of cytoplasmic proteins in canine heart. Circulation 99: 2458-2465.
25. Lader AS, Xiao YF, Ishikawa Y, Cui Y, Vatner DE, Vatner SF, Homey CJ and Cantiello HF (1998) Cardiac Gsalpha overexpression enhances L-type calcium channels through an adenylyl cyclase independent pathway. Proc Natl Acad Sci USA 95:9669-9674.
26. Lasley R, Prakash N, Uittenbogaard A and Smart E (2000) Activated cardiac adenosine A1 receptors translocate out of caveolae. J Biol Chem 275:4417-4421.
27. Lefkowitz RJ (1998) G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J Biol Chem 273: 18677-18680.
28. Liggett SB (1999) Molecular and genetic basis of beta2-adrenergic receptor function. J Allergy Clin Immunol 104:842-846.
29. Milano CA, Allen LF, Rockman HA, Dolber PC, McMinn TR, Chien KR, Johnson TD, Bond RA and Lefkowitz RJ (1994) Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science (Wash DC) 264:582-586.
30. Milligan G (1996) The stoichiometry of expression of protein components of the stimulatory adenylyl cyclase cascade and the regulation of information transfer. Cell Signal 8:87-95.
31. Mochizuki N, Urasawa K, Sanchez A and Insel PA (1995) Developmental regulation of the alpha-subunit of Gq/G11 as determined by quantitative immunoblot analysis. Biochem Biophys Res Commun 210:246-252.
32. Mochly-Rosen D and Gordon AS (1998) Anchoring proteins for protein kinase C: A means for isozyme selectivity. FASEB J 12:35-42.
33. Neubig RR (1994) Membrane organization in G-protein mechanisms. FASEB J 8:939-946.
34. Oh P and Schnitzer JE (1999) Immunoisolation of caveolae with high affinity antibody binding to the oligomeric caveolin cage. Toward understanding the basis of purification. J Biol Chem 274:23144-23154.
35. Okamoto T, Schlegel A, Scherer PE and Lisanti MP (1998) Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 273:5419-5422.
36. Pike LJ and Casey L (1996) Localization and turnover of phosphatidylinositol 4,5-bisphosphate in caveolin-enriched membrane domains. J Biol Chem 271:26453-26456.
37. Post SR, Hammond HK and Insel PA (1999) beta-Adrenergic receptors and receptor signaling in heart failure. Annu Rev Pharmacol Toxicol 39:343-360.
38. Post SR, Hilal-Dandan R, Urasawa K, Brunton LL and Insel PA (1995) Quantification of signalling components and amplification in the beta-adrenergic-receptor-adenylate cyclase pathway in isolated adult rat ventricular myocytes. Biochem J 311:75-80.
39. Raposo G, Dunia I, Delavier-Klutchko C, Kaveri S, Strosberg AD and Benedetti EL (1989) Internalization of beta-adrenergic receptor in A431 cells involves non-coated vesicles. Eur J Cell Biol 50:340-352.
40. Roth DM, Gao MH, Lai NC, Drumm J, Dalton N, Zhou JY, Zhu J, Entrikin D and Hammond HK (1999) Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy. Circulation 99:3099-3102.
41. Ruffolo RR Jr (1986) Spare alpha adrenoceptors in the peripheral circulation: Excitation-contraction coupling. Fed Proc 45:2341-2346.
42. Scholich K, Mullenix JB, Wittpoth C, Poppleton HM, Pierre SC, Lindorfer MA, Garrison JC and Patel TB (1999) Facilitation of signal onset and termination by adenylyl cyclase. Science (Wash DC) 283:1328-1331.
43. Shaul PW and Anderson RG (1998) Role of plasmalemmal caveolae in signal transduction. Am J Physiol 275:L843-L851.
44. Shih M, Lin F, Scott JD, Wang HY and Malbon CC (1999) Dynamic complexes of beta2-adrenergic receptors with protein kinases and phosphatases and the role of gravin. J Biol Chem 274:1588-1595.
45. Siegel H and Triggle DJ (1982) Benzilylcholine mustard and spare receptors in guinea pig ileum. Life Sci 30:1645-1652.
46. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel H, Sharma AM, Ritz E, Wichmann HE, Jakobs KH and Horethemke B (1998) Association of a human G-protein beta3 subunit variant with hypertension (see Comments). Nat Genet 18:45-48.
47. Song SK, Li S, Okamoto T, Quilliam LA, Sargiacomo M and Lisanti MP (1996) Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem 271:9690-9697.
48. Szabadkai G, Horváth A, Spat A and Enyedi P (1998) Expression of voltage-dependent calcium channel alphal subunits in rat adrenal capsular tissue and single glomerulosa cells. Endocr Res 24:425-426.
49. Toya Y, Schwencke C, Couet J, Lisanti MP and Ishikawa Y (1998) Inhibition of adenylyl cyclase by caveolin peptides. Endocrinology 139:2025-2031.
50. Wozniak M, Keefer JR, Saunders C and Limbird LE (1997) Differential targeting and retention of G protein-coupled receptors in polarized epithelial cells. J Recept Signal Transduct Res 17:373-383.
51. Zolk O, Kilter H, Flesch M, Mansier P, Swynghedauw B, Schnabel P and Böhm M (1998) Functional coupling of overexpressed beta 1-adrenoceptors in the myocardium of transgenic mice. Biochem Biophys Res Commun 248:801-805.